Zhejiang Starry Pharmaceutical
VC Fund
Hangzhou, China
Zhejiang Starry Pharmaceutical is a VC fund in Hangzhou focused on Biotechnology and Pharmaceutical. Zhejiang Starry Pharmaceutical Co., Ltd.(hereinafter referred to as Starry Pharma), established in 1997, is a national high-tech enterprise specialized in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Zhejiang Starry Pharmaceutical invests in
Stages Zhejiang Starry Pharmaceutical invests in
Countries Zhejiang Starry Pharmaceutical invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Pharmaceutical 2 (100%)
- Manufacturing 1 (50%)
- Medical Device 1 (50%)
Stage
- Series A 1 (50%)
- Corporate Round 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ruishi Pharmaceutical
|
Ruishi Pharmaceutical is an innovative company specializing in pharmaceutical CDMO (Contract Development and Manufacturing Organization) services, providing end-to-end solutions that include drug research and development, process optimization, clinical trial material production, and large-scale commercial manufacturing, while maintaining highstandards of quality, regulatory compliance, and technological expertise to support global pharmaceutical partners. | Corporate Round / Mar 23, 2026 | |
Yannuo Pharmaceutical
|
Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conductsresearch and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas. | Series A / Jul 07, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Zhejiang Starry Pharmaceutical invest in?
Zhejiang Starry Pharmaceutical invests primarily in Biotechnology, Pharmaceutical and Manufacturing startups, most often at Series A and Corporate Round stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Zhejiang Starry Pharmaceutical last invest?
The most recent investment recorded for Zhejiang Starry Pharmaceutical closed in Mar 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
